Periodic Reporting for period 1 - CanceRusolution (A NEW DRUG TO TREAT TRIPLE NEGATIVE BREAST CANCER)

Survival rates for patients with Triple Negative Breast Cancer (TNBC) are as low as 11%. This type of breast cancer is more aggressive and with a poor prognosis since, at a very early stage, it develops metastases, i.e., secondary tumors in other organs. While patients with...